互联网 qkzz.net
全刊杂志网:首页 > 医药医学 > 《临床肿瘤学医学期刊》 > 2005年第01期
《临床肿瘤学医学期刊》
临床肿瘤学医学期刊2005年第01期封面 购买
收藏
投稿

《临床肿瘤学医学期刊》2005年第01期

impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment
sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates
sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer
effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group b 9344
invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes
detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance ima..
tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase ii t..
organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a southwest oncology group trial
status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution
randomized phase ii evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (g-csf) compared with 12 g/m2 of ifosfamide plus d..
autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospec..
risk-reducing salpingo-oophorectomy in brca mutation carriers: role of serial sectioning in the detection of occult malignancy
randomized phase iii trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage iiib or iv non-small-cell lung cancer: a phase iii randomized study ..
wild-type p53 overexpression and its correlation with mdm2 and p14arf alterations: an alternative pathway to non
practical management of patients with non
clinical model to predict survival in chemonaive patients with advanced non
statistical validation of the eortc prognostic model for malignant pleural mesothelioma based on three consecutive phase ii trials
single-agent versus combination chemotherapy in advanced non
malignant breast tumors after radiotherapy for a first cancer during childhood
model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients
prediction of docetaxel response in human breast cancer by gene expression profiling
up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial
long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period ana..
downregulation of smac/diablo expression in renal cell carcinoma and its prognostic significance
randomized phase ii study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the national cancer institute of canada-clinical trials group
phase i trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-hodgkin's lymphoma
role of anti-hepatitis c virus (hcv) treatment in hcv-related, low-grade, b-cell, non-hodgkin's lymphoma: a multicenter italian experience
polymorphisms in fc{gamma}riiia (cd16) receptor expression are associated with clinical response to rituximab in waldenstrm’s macroglobulinemia
outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group b study
docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase ii study
intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase ii study
racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients
phase i clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium stud..
prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma
results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the nb 97 french society of pediatric oncology (sfop) prot..
advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine ..
ewing sarcomas with p53 mutation or p16/p14arf homozygous deletion: a highly lethal subset associated with poor chemoresponse
osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the cooperative osteosarcoma study group (coss)
platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase ii study assessing attenuated-dose or ful..
phase ii study of et-743 in advanced soft tissue sarcomas: a european organisation for the research and treatment of cancer (eortc) soft tissue and bone sarcoma gro..
imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a princess margaret hospital phase ii consortium study
quality-of-life assessment in the symptom management trials of the national cancer institute-supported community clinical oncology program
long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation
american society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor
proteasome inhibition as a novel therapeutic target in human cancer
购买 收藏 投稿
往期回顾
2006年第20期
2006年第02期
2006年第01期
2005年第12期
2005年第11期
2005年第10期
2005年第09期
2005年第08期
2005年第07期
2005年第06期
2005年第05期
2005年第04期
关键字
支持中国杂志产业发展,请购买、订阅纸质杂志,欢迎杂志社提供过刊、样刊及电子版。
关于我们 | 网站声明 | 刊社管理 | 网站地图 | 联系方式 | 中图分类法 | RSS 2.0订阅 | IP查询
全刊杂志赏析网 2017